PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers

被引：0
|
作者：
Rui Liu
Youwen Chen
Guangzhi Liu
Chenxi Li
Yurong Song
Zhiwen Cao
Wen Li
Jinghong Hu
Cheng Lu
Yuanyan Liu
机构：
[1] Beijing University of Chinese Medicine,School of Chinese Materia Medica
[2] China Academy of Chinese Medical Sciences,Institute of Basic Research in Clinical Medicine
来源：
Cell Death & Disease | / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
    Liu, Rui
    Chen, Youwen
    Liu, Guangzhi
    Li, Chenxi
    Song, Yurong
    Cao, Zhiwen
    Li, Wen
    Hu, Jinghong
    Lu, Cheng
    Liu, Yuanyan
    CELL DEATH & DISEASE, 2020, 11 (09)
  • [2] Activation of the PI3K/Akt pathway and chemotherapeutic resistance
    West, KA
    Castillo, SS
    Dennis, PA
    DRUG RESISTANCE UPDATES, 2002, 5 (06) : 234 - 248
  • [3] Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
    A Bhatt
    P Bhende
    B Damania
    Infectious Agents and Cancer, 4 (Suppl 2)
  • [4] Link between PI3K/AKT/PTEN Pathway and NOX Protein in Diseases
    Nakanishi, Atsuko
    Wada, Yoko
    Kitagishi, Yasuko
    Matsuda, Satoru
    AGING AND DISEASE, 2014, 5 (03): : 203 - 211
  • [5] FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway
    L Cheng
    S Luo
    C Jin
    H Ma
    H Zhou
    L Jia
    Cell Death & Disease, 2013, 4 : e923 - e923
  • [6] FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway
    Cheng, L.
    Luo, S.
    Jin, C.
    Ma, H.
    Zhou, H.
    Jia, L.
    CELL DEATH & DISEASE, 2013, 4 : e923 - e923
  • [7] PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines
    Garcia, Mariana G.
    Alaniz, Laura D.
    Cordo Russo, Rosalia I.
    Alvarez, Elida
    Hajos, Silvia E.
    LEUKEMIA RESEARCH, 2009, 33 (02) : 288 - 296
  • [8] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [9] PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation
    Kita, Keisuke
    Kimura, Tohru
    Nakamura, Norimasa
    Yoshikawa, Hideki
    Nakano, Toru
    GENES TO CELLS, 2008, 13 (08) : 839 - 850
  • [10] PI3K/Akt Pathway Mutations in Retinoblastoma
    Cohen, Yoram
    Merhavi-Shoham, Efrat
    Avraham-Lubin, Bat Chen R.
    Savetsky, Michael
    Frenkel, Shahar
    Pe'er, Jacob
    Goldenberg-Cohen, Nitza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (11) : 5054 - 5056
12345